Is there a generic for Loracarbef?

The FDA Orange Book does not currently list an approved generic (ANDA) for Loracarbef. It is available as 2 brand (NDA) applications.

What is the reference-listed drug for Loracarbef?

LORABID (NDA 050668, KING PHARMS) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Loracarbef are approved?

Loracarbef is approved in the following dosage forms: capsule, for suspension.

FDA Orange Book · active-ingredient family

Loracarbef

Loracarbef is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:LORABID · NDA 050668

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · capsule, for suspension

Product	Applicant	Application	TE	Approved
LORABID×2	KING PHARMS	NDA 050668	—	Dec 31, 1991
LORABID×2	KING PHARMS	NDA 050667	—	Dec 31, 1991

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Loracarbef — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo